VYTORIN Side Effects

7029392-4 | Asthenia, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Myalgia
on Mar 04, 2010 Male patient from UNITED STATES , 70 years of age, was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatine phosphokinase increased, liver function test abnormal, myalgia. Vytorin dosage: 10-40 Mg/daily/po. During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

7029387-0 | Rhabdomyolysis
Patient was taking Vytorin (View Usage). Patient had the following side effects: rhabdomyolysis on Jun 20, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with blood cholesterol increased and. Vytorin dosage: 10-40 Mg/daily/po. Patient was hospitalized.

7029384-5 | Swelling Face
Adverse event was reported on Jun 08, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: 10/20 Mg/daily/po) was diagnosed with hypercholesterolaemia and. Location: UNITED STATES , 65 years of age, After Vytorin was administered, patient had the following side effects: swelling face. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

7029353-5 | Systemic Lupus Erythematosus, Weight Decreased
on Jun 25, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: systemic lupus erythematosus, weight decreased. Vytorin dosage: 10 Mg-20 Mg/daily/po. During the same period patient was treated with CENTRUM (View Centrum Review and Centrum Label ), CITRACAL + D (View Citracal + D Review and Citracal + D Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEGA 3 ACID ETHYL ESTERS (LOVAZA) (View Omega-3-acid Ethyl Esters (lovaza) Review and Omega-3-acid Ethyl Esters (lovaza) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).


7029328-6 | Abdominal Discomfort, Activities Of Daily Living Impaired, Gastroenteritis Viral, Headache, Hot Flush
on Sep 25, 2010 Male patient from UNITED STATES , 77 years of age, was diagnosed with cardiac operation and was treated with Vytorin (View Usage). Patient had the following side effects: abdominal discomfort, activities of daily living impaired, gastroenteritis viral, headache (What is headache?), hot flush. Vytorin dosage: 10-40 Mg/daily/po. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), PROTEGRA (View Protegra Review and Protegra Label ). Patient was hospitalized.

7029327-4 | Pancreatitis
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: pancreatitis on Sep 24, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with hyperlipidaemia and. Vytorin dosage: 10/20 Mg/daily/po. During the same period patient was treated with CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ).

7029316-X | Rhabdomyolysis
Adverse event was reported on Oct 15, 2009 by a Female patient taking Vytorin (View Usage) (Dosage: 10/40 Mg/daily/po) . Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. During the same period patient was treated with LOPID (View Lopid Review and Lopid Label ). Patient was hospitalized.

7029301-8 | Nausea
on Oct 16, 2009 Male patient from UNITED STATES , 32 years of age, was diagnosed with blood cholesterol increased and was treated with Vytorin (View Usage). Patient had the following side effects: nausea (What is nausea?). Vytorin dosage: 10-40 Mg/daily/po.

7029299-2 | Rhabdomyolysis
on Oct 19, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: rhabdomyolysis. Vytorin dosage: 10/80 Mg/daily/po. During the same period patient was treated with CALTRATE (View Caltrate Review and Caltrate Label ), LASIX (View Lasix Review and Lasix Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

7029296-7 | Dry Mouth, Neuropathy Peripheral, Tooth Disorder, Tooth Erosion, Tooth Loss
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, neuropathy peripheral, tooth disorder (What is tooth disorder?), tooth erosion, tooth loss on Nov 11, 2009 from UNITED STATES Additional patient health information: Female patient , 90 years of age, . Vytorin dosage: Po. Patient was hospitalized.

7029274-8 | Myalgia
Adverse event was reported on Nov 16, 2009 by a Female patient taking Vytorin (View Usage) (Dosage: 10-80 Mg/daily/po) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: myalgia. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), TRAVATAN (View Travatan Review and Travatan Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

7029273-6 | Cholelithiasis, Gastrointestinal Disorder
on Nov 19, 2009 Male patient from UNITED STATES , 53 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: cholelithiasis, gastrointestinal disorder. Vytorin dosage: 10/10 Mg/daily/po. Patient was hospitalized.

7029272-4 | Arthralgia
on Dec 23, 2009 Female patient from UNITED STATES , 61 years of age, was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia. Vytorin dosage: 10-40 Mg/daily/po. During the same period patient was treated with DARVOCET (View Darvocet Review and Darvocet Label ), XANAX (View Xanax Review and Xanax Label ).

7029244-X | Cholecystitis
Patient was taking Vytorin (View Usage). Patient had the following side effects: cholecystitis on Jul 27, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with blood cholesterol increased and. Vytorin dosage: Po. Patient was hospitalized.

7029243-8 | Rhabdomyolysis
Adverse event was reported on Aug 07, 2009 by a Male patient taking Vytorin (View Usage) (Dosage: 10-80 Mg/daily/po) was diagnosed with blood cholesterol increased, diabetes mellitus and. Location: UNITED STATES , 51 years of age, weighting 190.0 lb, After Vytorin was administered, patient had the following side effects: rhabdomyolysis. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), DEPAKOTE (View Depakote Review and Depakote Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FLUOXYMESTERONE (View Fluoxymesterone Review and Fluoxymesterone Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

7018630-X | Asthenia, Insomnia, Muscle Spasms, Myalgia, Paralysis, Suicidal Ideation
on Sep 24, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, insomnia, muscle spasms, myalgia, paralysis (What is paralysis?), suicidal ideation. Vytorin dosage: . Patient was hospitalized.

7016117-1 | Acute Myocardial Infarction, Angina Unstable, Arteriosclerosis, Cardiogenic Shock, Coronary Artery Disease, Haemoptysis, Haemorrhage, Hypochromic Anaemia, Hypovolaemic Shock
on Sep 15, 2010 Male patient from COLOMBIA , 66 years of age, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient had the following side effects: acute myocardial infarction, angina unstable, arteriosclerosis, cardiogenic shock, coronary artery disease (What is coronary artery disease?), haemoptysis, haemorrhage, hypochromic anaemia, hypovolaemic shock. Vytorin dosage: 10-40mg/daily Po. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

7010872-2 | Hepatitis B, Rhabdomyolysis
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: hepatitis b (What is hepatitis b?), rhabdomyolysis on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with blood cholesterol increased and. Vytorin dosage: . During the same period patient was treated with NORCO (5/500 One Bid Prn) (View Norco Review and Norco Label ), ALBUTEROL (Prn) (View Albuterol Review and Albuterol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), DECADRON (View Decadron Review and Decadron Label ), REVLIMID (View Revlimid Review and Revlimid Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LORAZEPAM (Half Tab To One Tab Tid Prn) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

7008716-8 | Haemoptysis, Hypochromic Anaemia, Melaena, Pulmonary Alveolar Haemorrhage
Adverse event was reported on Sep 09, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: 10-40 Mg/daily Po) was diagnosed with acute coronary syndrome and. Location: COLOMBIA , 66 years of age, Patient experienced the following unwanted or unexpected effects: haemoptysis, hypochromic anaemia, melaena, pulmonary alveolar haemorrhage. Patient was hospitalized.

7007822-1 | Ankle Fracture, Muscle Rupture
on Sep 16, 2010 Male patient from GERMANY , 70 years of age, weighting 180.8 lb, was diagnosed with hyperlipidaemia and was treated with Vytorin (View Usage). Patient had the following side effects: ankle fracture, muscle rupture. Vytorin dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (View Candesartan Cilexetil And Hydrochlorothiazide Review and Candesartan Cilexetil And Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7005737-6 | Anxiety, Asthenia, Hypertension, Malaise, Muscle Disorder, Spinal Disorder
on Sep 16, 2010 Male patient from UNITED STATES , 43 years of age, was diagnosed with blood cholesterol increased and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: anxiety (What is anxiety?), asthenia, hypertension, malaise, muscle disorder (What is muscle disorder?), spinal disorder. Vytorin dosage: . During the same period patient was treated with AVALIDE (View Avalide Review and Avalide Label ), XANAX (View Xanax Review and Xanax Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6992695-3 | Adverse Event, Helicobacter Infection
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, helicobacter infection on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, . Vytorin dosage: . Patient was hospitalized.

6992271-2 | Inflammation, Motor Dysfunction, Pain
Adverse event was reported on Sep 15, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: 1 Tablet 1x Day Po) was diagnosed with blood cholesterol increased, hypertension, myocardial infarction and. Location: UNITED STATES , 80 years of age, weighting 170.0 lb, Patient had the following side effects: inflammation, motor dysfunction, pain (What is pain?).

6981100-9 | Ankle Fracture, Muscle Rupture
on Sep 08, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: ankle fracture, muscle rupture. Vytorin dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (View Candesartan Cilexetil And Hydrochlorothiazide Review and Candesartan Cilexetil And Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6979221-X | Thyroid Cancer
on Aug 24, 2010 Male patient from UNITED STATES , 65 years of age, weighting 203.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: thyroid cancer (What is thyroid cancer?). Vytorin dosage: Daily, Po. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

6977559-3 | Asthma, Cough, Dyspnoea Exertional, Eosinophilia, Restrictive Pulmonary Disease, Sinusitis
Patient was taking Vytorin (View Usage). Patient had the following side effects: asthma (What is asthma?), cough, dyspnoea exertional, eosinophilia, restrictive pulmonary disease, sinusitis (What is sinusitis?) on Sep 08, 2010 from FRANCE Additional patient health information: Male patient , 59 years of age, was diagnosed with hypercholesterolaemia, gastrooesophageal reflux disease, prostatic adenoma, bone pain and. Vytorin dosage: . During the same period patient was treated with INFLUENZA VIRUS A SPLIT VIRION VACCINE INACTIVATED (H1N1) (View Influenza Virus A Split Virion Vaccine Inactivated (h1n1) Review and Influenza Virus A Split Virion Vaccine Inactivated (h1n1) Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ). Patient was hospitalized.

6977093-0 | Anxiety, Asthenia, Hypertension, Malaise, Muscle Disorder, Spinal Disorder
Adverse event was reported on Sep 07, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 43 years of age, After Vytorin was administered, patient had the following side effects: anxiety (What is anxiety?), asthenia, hypertension, malaise, muscle disorder (What is muscle disorder?), spinal disorder. During the same period patient was treated with AVALIDE (View Avalide Review and Avalide Label ), XANAX (View Xanax Review and Xanax Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6977091-7 | Ankle Fracture, Muscle Rupture
on Sep 08, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: ankle fracture, muscle rupture. Vytorin dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (View Candesartan Cilexetil And Hydrochlorothiazide Review and Candesartan Cilexetil And Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6968370-8 | Anxiety, Arthralgia, Chest Discomfort, Fatigue, Headache, Hypoaesthesia, Insomnia, Joint Stiffness
on Sep 03, 2010 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with blood cholesterol increased and was treated with Vytorin (View Usage). Patient had the following side effects: anxiety (What is anxiety?), arthralgia, chest discomfort, fatigue, headache (What is headache?), hypoaesthesia, insomnia, joint stiffness. Vytorin dosage: 10/80 Mg 1 Daily Oral.

6959366-0 | Diarrhoea, Gait Disturbance, Pain In Extremity
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: diarrhoea, gait disturbance, pain in extremity on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 127.0 lb, was diagnosed with blood cholesterol increased and. Vytorin dosage: One A Day Po.

6955948-0 | Alopecia, Aortic Stenosis, Arthralgia, Back Pain, Blister, Blood Creatine Phosphokinase Increased, Bursitis Infective, Carotid Artery Stenosis
Adverse event was reported on Aug 25, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: alopecia, aortic stenosis, arthralgia, back pain (What is back pain?), blister, blood creatine phosphokinase increased, bursitis infective, carotid artery stenosis. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), MANTAI (View Mantai Review and Mantai Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALTACE (View Altace Review and Altace Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized and became disabled.

6945637-0 | Diverticulitis
on Aug 25, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). Patient had the following side effects: diverticulitis. Vytorin dosage: . During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6945630-8 | Cough, Dyspnoea Exertional, Restrictive Pulmonary Disease, Sinusitis
on Aug 17, 2010 Male patient from FRANCE , 59 years of age, was diagnosed with hypercholesterolaemia, gastrooesophageal reflux disease, prostatic adenoma, bone pain and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: cough, dyspnoea exertional, restrictive pulmonary disease, sinusitis (What is sinusitis?). Vytorin dosage: . During the same period patient was treated with INFLUENZA VIRUS A SPLIT VIRION VACCINE INACTIVATED (H1N1) (View Influenza Virus A Split Virion Vaccine Inactivated (h1n1) Review and Influenza Virus A Split Virion Vaccine Inactivated (h1n1) Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6945627-8 | Muscle Atrophy, Muscular Weakness
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: muscle atrophy, muscular weakness on Aug 24, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 160.9 lb, was diagnosed with hyperlipidaemia, depression (What is depression?), hypertension, diabetes mellitus and. Vytorin dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PAXIL (View Paxil Review and Paxil Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

6942540-7 | Metastases To Liver, Metastases To Lung, Metastases To Lymph Nodes, Rectal Cancer
Adverse event was reported on Aug 09, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: 10-40 Mg/daily/po) was diagnosed with acute coronary syndrome and. Location: UNITED KINGDOM , 82 years of age, weighting 180.0 lb, Patient had the following side effects: metastases to liver, metastases to lung, metastases to lymph nodes, rectal cancer. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6935856-1 | Bladder Cancer Recurrent, Urinary Bladder Polyp
on Aug 03, 2010 Male patient from ISRAEL , 67 years of age, weighting 198.0 lb, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: bladder cancer recurrent, urinary bladder polyp. Vytorin dosage: 10-40 Mg Daily Po. During the same period patient was treated with LANTON (View Lanton Review and Lanton Label ), TRITACE (View Tritace Review and Tritace Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6932490-4 | Diverticulitis
on Aug 17, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: diverticulitis. Vytorin dosage: . During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6926006-6 | Bladder Cancer Recurrent, Bladder Neoplasm, Lung Neoplasm Malignant, Urinary Bladder Polyp
Patient was taking Vytorin (View Usage). Patient had the following side effects: bladder cancer recurrent, bladder neoplasm, lung neoplasm malignant, urinary bladder polyp on Aug 03, 2010 from ISRAEL Additional patient health information: Male patient , 67 years of age, was diagnosed with acute coronary syndrome and. Vytorin dosage: 10-40 Mg/daily Po. During the same period patient was treated with LANTON (View Lanton Review and Lanton Label ), TRITACE (View Tritace Review and Tritace Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6925584-0 | Renal Failure, Rhabdomyolysis
Adverse event was reported on Aug 12, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: FRANCE , 65 years of age, After Vytorin was administered, patient had the following side effects: renal failure, rhabdomyolysis. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PERINDOPRIL ARGININE (View Perindopril Arginine Review and Perindopril Arginine Label ), INDAPAMIDE AND PERINDOPRIL ARGININE (View Indapamide And Perindopril Arginine Review and Indapamide And Perindopril Arginine Label ), NOVOMIX (View Novomix Review and Novomix Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), TEMERIT (View Temerit Review and Temerit Label ). Patient was hospitalized.

6923376-X | Muscle Atrophy, Muscular Weakness
on Aug 10, 2010 Male patient from UNITED STATES , 50 years of age, weighting 160.9 lb, was diagnosed with hyperlipidaemia, depression (What is depression?), hypertension, diabetes mellitus and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: muscle atrophy, muscular weakness. Vytorin dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), PAXIL (View Paxil Review and Paxil Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

6922883-3 | Cholelithiasis, Gallbladder Cancer, Metastases To Liver
on Aug 05, 2010 Female patient from UNITED STATES , 88 years of age, was treated with Vytorin (View Usage). Patient had the following side effects: cholelithiasis, gallbladder cancer (What is gallbladder cancer?), metastases to liver. Vytorin dosage: Po. During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ).

6915545-X | Aggression, Delusion, Personality Change, Psychotic Disorder, Status Epilepticus
Patient was taking Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: aggression, delusion, personality change, psychotic disorder (What is psychotic disorder?), status epilepticus on Jul 23, 2010 from GERMANY Additional patient health information: Male patient , 67 years of age, weighting 233.0 lb, was diagnosed with acute coronary syndrome and. Vytorin dosage: 10-40 Mg/daily/po. During the same period patient was treated with APO AMITRYPTILLINE (View Apo-amitryptilline Review and Apo-amitryptilline Label ), CARMEN (View Carmen Review and Carmen Label ), MICARDIS (View Micardis Review and Micardis Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ). Patient was hospitalized.

6915221-3 | Convulsion, Impaired Driving Ability, Loss Of Employment
Adverse event was reported on Aug 05, 2010 by a Female patient taking Vytorin (View Usage) (Dosage: Qd Po) was diagnosed with blood triglycerides increased and. Location: UNITED STATES , 54 years of age, weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: convulsion, impaired driving ability, loss of employment. Patient was hospitalized.

6911145-6 | Diverticulitis
on Aug 02, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with blood cholesterol and was treated with Vytorin (View Usage). Patient had the following side effects: diverticulitis. Vytorin dosage: . During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6902155-3 | Hepatic Encephalopathy, Hepatic Necrosis
on Aug 02, 2010 Female patient from GERMANY , 67 years of age, weighting 165.3 lb, was diagnosed with hyperlipidaemia, hyperuricaemia and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: hepatic encephalopathy, hepatic necrosis. Vytorin dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6902151-6 | Hypokalaemia, Renal Failure Acute, Rhabdomyolysis, Subileus
Patient was taking Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, renal failure acute, rhabdomyolysis, subileus on Aug 02, 2010 from GERMANY Additional patient health information: Male patient , 62 years of age, weighting 220.5 lb, was diagnosed with coronary artery disease (What is coronary artery disease?), arteriosclerosis and. Vytorin dosage: . Patient was hospitalized.

6877167-9 | Dyspnoea, Muscle Atrophy, Muscle Rupture, Rotator Cuff Syndrome
Adverse event was reported on Jul 27, 2010 by a Male patient taking Vytorin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 74 years of age, weighting 240.0 lb, Patient had the following side effects: dyspnoea, muscle atrophy, muscle rupture, rotator cuff syndrome.

6877036-4 | Arrhythmia, Blood Creatinine Increased, Coagulopathy, Fatigue, Jaundice, Malaise, Mental Status Changes
on Jul 27, 2010 Female patient from UNITED STATES , 57 years of age, weighting 145.5 lb, was diagnosed with hypercholesterolaemia and was treated with Vytorin (View Usage). After Vytorin was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), blood creatinine increased, coagulopathy, fatigue, jaundice (What is jaundice?), malaise, mental status changes. Vytorin dosage: Oral 047. Patient was hospitalized.

6874551-4 | Nephrolithiasis
on Jul 16, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with acute coronary syndrome and was treated with Vytorin (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis. Vytorin dosage: 10/40 Mg/daily. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6867333-0 | Coronary Artery Disease, Joint Dislocation, Myalgia, Myocardial Infarction, Rib Fracture, Road Traffic Accident
Patient was taking Vytorin (View Usage). Patient had the following side effects: coronary artery disease (What is coronary artery disease?), joint dislocation, myalgia, myocardial infarction, rib fracture, road traffic accident on Jul 20, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 165.3 lb, was diagnosed with blood cholesterol increased, stent placement and. Vytorin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), TYLENOL (View Tylenol Review and Tylenol Label ), OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ), CHONDROITIN SULFATE SODIUM AND GLUCOSAMINE SULFATE (View Chondroitin Sulfate Sodium And Glucosamine Sulfate Review and Chondroitin Sulfate Sodium And Glucosamine Sulfate Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.